CH488712A - Process for the preparation of benzodiazepine derivatives - Google Patents
Process for the preparation of benzodiazepine derivativesInfo
- Publication number
- CH488712A CH488712A CH1642169A CH1642169A CH488712A CH 488712 A CH488712 A CH 488712A CH 1642169 A CH1642169 A CH 1642169A CH 1642169 A CH1642169 A CH 1642169A CH 488712 A CH488712 A CH 488712A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- halogen
- hydrogen
- compound
- process according
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 238000002360 preparation method Methods 0.000 title claims description 5
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title claims description 4
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims description 15
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- -1 alkyl peroxide Chemical class 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 230000002140 halogenating effect Effects 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 2
- 239000012933 diacyl peroxide Substances 0.000 claims description 2
- 238000006193 diazotization reaction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 150000002976 peresters Chemical class 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 239000012320 chlorinating reagent Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- 230000026030 halogenation Effects 0.000 description 2
- 238000005658 halogenation reaction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- RGGLEJFUEMKQSH-UHFFFAOYSA-N 1,4-benzodiazepin-2-one Chemical class O=C1C=NC=C2C=CC=CC2=N1 RGGLEJFUEMKQSH-UHFFFAOYSA-N 0.000 description 1
- NOXIPAREWUQUGI-UHFFFAOYSA-N 3,7-dichloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(Cl)N=C1C1=CC=CC=C1 NOXIPAREWUQUGI-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- TUINAAYXMRLCEA-UHFFFAOYSA-N 3-amino-7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(N)N=C1C1=CC=CC=C1 TUINAAYXMRLCEA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WHTNHYRHHHFFBV-UHFFFAOYSA-N ClNS(=O)=O Chemical compound ClNS(=O)=O WHTNHYRHHHFFBV-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NXTVQNIVUKXOIL-UHFFFAOYSA-N N-chlorotoluene-p-sulfonamide Chemical compound CC1=CC=C(S(=O)(=O)NCl)C=C1 NXTVQNIVUKXOIL-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HSPSCWZIJWKZKD-UHFFFAOYSA-N n-chloroacetamide Chemical compound CC(=O)NCl HSPSCWZIJWKZKD-UHFFFAOYSA-N 0.000 description 1
- CHVZPRDGLWBEMJ-UHFFFAOYSA-N n-chlorobenzenesulfonamide Chemical compound ClNS(=O)(=O)C1=CC=CC=C1 CHVZPRDGLWBEMJ-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- AKPLHCDWDRPJGD-UHFFFAOYSA-N nordazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1 AKPLHCDWDRPJGD-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- GJBRNHKUVLOCEB-UHFFFAOYSA-N tert-butyl benzenecarboperoxoate Chemical compound CC(C)(C)OOC(=O)C1=CC=CC=C1 GJBRNHKUVLOCEB-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Verfahren zur Herstellung von Benzodiazepin-Derivaten Die Erfindung betrifft ein neues Verfahren zur Her stellung von Benzodiazepin-Derivaten und zwar von 1,4 -Benzodiazepin-2-onen der allgemeinen Formel
EMI0001.0003
worin A Phenyl, Monohalogenphenyl oder Pyridyl, R, und R_ Wasserstoff, Halogen, Nitro, Trifluormethyl oder Alkyl bis zu 7 Kohlenstoffatomen und R., Wasserstoff oder Alkyl bis zu 7 C-Atomen bedeuten.
Das erfindungsgemässe Verfahren ist dadurch ge kennzeichnet, dass man eine Verbindung der Formel
EMI0001.0013
worin A, R,, R, und R, die vorstehend angegebene Be deutung haben, mit einem Halogenierungsmittel, das eine
EMI0001.0017
Gruppe aufweist, worin X Halogen bedeutet, um setzt und die erhaltene 3-Halogenverbindung mit Am moniak behandelt.
Verbindungen der Formel I können zur Herstellung der entsprechenden, in 3-Stellung durch eine Hydroxy- gruppe substituierten Verbindungen verwendet werden; hierbei wird die Aminogruppe in 3-Stellung in eine Hy- droxygruppe umgewandelt.
Bevorzugte Halogenierungsmittel mit einer
EMI0001.0028
Gruppe sind solche, worin X Chlor, Brom oder Jod be deutet; besonders geeignet sind Verbindungen der Formel
EMI0001.0029
in welchen Formeln X Halogen, vorzugsweise Chlor, Brom oder Jod und R" Wasserstoff oder Alkyl bis zu 7 C-Atomen bedeuten und der mit I bezeichnete Ring substituiert oder unsubstituiert sein kann. Wenn der Ring substituiert ist, dann ist niederes Alkyl als Substi- tuent bevorzugt.
Die Formeln IIIa, IIlb und 1lIc umfassen Verbin dungen wie N-Chlorsuccinimid, N-Bromsuccinimid, N- Halo-niederes Alkanoylamid, z.B. N-Chloracetamid, N- Chlorsulfonamid wie N-Chlorbenzolsulfonamid, N-Chlor- -p-toluolsulfonamid u. dgl.
Jeder Radikale bildende Katalysator, der die Haloge- nierung von Verbindungen der Formel II bewirkt, ist in dem erfindungsgemässen Verfahren anwendbar. Ge eignete Katalysatoren sind Azo-bis-niederalkylnitrile wie Azobisisobutyronitril, Diniederalkylperoxyde wie di-tert. -Butylperoxyde, Diacylperoxydewie Diniederalkanoylper- oxyde (z.B. Acetylperoxyd),
Perester wie tert.-Butylper- benzoat und tert.-Butylperphthalat, Hydroperoxyde wie tert.-Butylhydroperoxyd, Cumolhydroperoxyd und der gleichen. Bevorzugt ist Azodiisobutyronitril.
In einer bevorzugten Ausführungsform wird die 1-Talo- genierung in einem inerten organischen Lösungsmittel durchgeführt. Geeignete inerte organische Lösungsmittel sind aromatische Kohlenwasserstoffe wie Benzol, Xylol, Toluol und dgl; chlorierte Kohlenwasserstoffe wie Chlor benzol, Tetrachlorkohlenstoff und dgl. Temperatur und Druck sind bei diesem Verfahrensschritt nicht von Be lang und es kann daher bei Raumtemperatur und At mosphärendruck oder oberhalb Raumtemperatur gear beitet werden.
Es ist jedoch jedem Fachmann geläufig, dass die Temperatur, bei der die Halogenierung von Verbindungen der Formel 1I durchgeführt wird, teil weise durch den Katalysator bestimmt wird. Es ist be kannt, dass einige Radikalbildungen die durch Spaltung einer Bindung hervorgerufen werden, bei Raumtempera tur erfolgen. Die Reaktion kann daher bei Raumtempe ratur durchgeführt werden, wenn man einen Katalysator einsetzt, der bei Raumtemperatur dissoziiert. Die mei sten Radikale bildenden Katalysatoren dissoziieren jedoch erst oberhalb Raumtemperatur. Es ist daher bevorzugt, diesen Schritt bei geeigneten Temperaturen, vorzugs weise bei Rückflusstemperatur des Reaktionsmediums durchzuführen.
Die zweite Stufe des erfindungsgemässen Verfahrens umfasst die Umwandlung der 3-H < < logen-1,4-benzodi2tze- pine in entsprechenden Verbindungen der Formel 1.
Dies kann durch Behandlung einer 3-Halogen-Ver- bindung mit Ammoniak in Gegenwart eines inerten or ganischen Lösungsmittels, wie Dichlormethan, erfolgen.
Die erhaltene 3-Amino-Verbindungen der Formel I kiinnen erwünschtenfalls durch Diazotierung und an- schliessendes Erwärmen mit Wasser in 3-Hydroxy-Ver- binduncen übergeführt werden.
Der Ausdruck All < yl bis zu 7 C-Atomen umfasst ver zweigte und unverzweiete Kohlenwasserstoffgruppen, wie Meth-,I, Äthyl, n-Propyl, Isopropyl, Isobutyl und dgl. Der Ausdruck (#Halogena umfasst alle 4-Halogene, d.h. Jod, Brom, Chlor und Fluor, wenn nicht anders gegeben.
Der Ausdruck eniederes .Acyl.) bezeichnet Acylreste von aro matischen Carbonsäuren, wie Benzoyl oder einen ver zweigten oder unverzweigten niederen Alkanoylrest, z.B. Acetyl, Propionyl und dgl. Geeignete .Alkali und Erdal- kalimetalle sind Natrium. Kalium, Calcium, Magnesium und dal.
In@Verbinduneen der Formel 1 bedeutet A vorzugs weise Phenyl oder 7.-Pyridyl, R vorzugsweise Wasser stoff und R, ist bevorzugt Halogen, besonders bevorzugt Chlor.
tni folcenden Beispiel sind alle Temperaturen in C an gegeben. <I>Beispiel</I> Eine Lösung von 5,4 g (0,02 Mol) 7-Chlor-1,3-dihy- dro-5-phenyl-2H-1,4-benzodiazepin-2-on, 3 g (0,022 Mol) N-Chlorsuccinimid, 0,1g Azodiisobutyronitril und 200 ml Benzol wird 1 Stunde am Rückfluss erhitzt.
Die erhal tene Suspension wird zur Trockene eingedampft und der Rückstand, der 3,7-Dichlor-1,3-dihydro-5-phenyl-2H-1,4- -benzodiazepin-2-on enthält wird in 50 ml Dichlorme- than suspendiert. Die erhaltene Suspension wird un ter Rühren ztr 100 ml Dichlormethan, das mit Ammoniak gesättigt ist, gegebzn. Die Mischung wird 1 Stunde in einem Eisbad und 3 Stunden bei Raumtemperatur gerührt. Das Dichlormethan wird im Vakuum entfernt. Der ölige Rückstand wird in 35 ml Acetonitril aufgenommen und zum Rückfluss erhitzt.
Nach dem Filtrieren wird das Acetonitrilfiltrat zur Trok- kene eingedampft. Fraktionierte Umkristallisation des Rückstandes aus Äthanol gibt rotbraunes 3-Amino-7- - chlor-1,3 - d ihyd ro-5-phenyl-2H-1,4 - benzod iazepin-2-on vom Schmelzpunkt 187 - 192 (Zerr.). Nach Umkristalli sation aus Acetonitril erhält man schwach braune Kri stalle vom Schmelzpunkt 218 - 22t) (Zers.).
Process for the preparation of benzodiazepine derivatives The invention relates to a new process for the preparation of benzodiazepine derivatives, namely 1,4-benzodiazepin-2-ones of the general formula
EMI0001.0003
where A is phenyl, monohalophenyl or pyridyl, R, and R_ are hydrogen, halogen, nitro, trifluoromethyl or alkyl up to 7 carbon atoms and R, hydrogen or alkyl up to 7 carbon atoms.
The inventive method is characterized in that a compound of the formula
EMI0001.0013
wherein A, R ,, R, and R, have the meaning given above Be, with a halogenating agent, the one
EMI0001.0017
Has group in which X is halogen, to sets and the 3-halogen compound obtained is treated with ammonia.
Compounds of the formula I can be used to prepare the corresponding compounds substituted in the 3-position by a hydroxyl group; here the amino group in the 3-position is converted into a hydroxy group.
Preferred halogenating agents with a
EMI0001.0028
Groups are those in which X is chlorine, bromine or iodine; Compounds of the formula are particularly suitable
EMI0001.0029
in which formulas X is halogen, preferably chlorine, bromine or iodine and R "is hydrogen or alkyl up to 7 carbon atoms and the ring labeled I can be substituted or unsubstituted. If the ring is substituted, then lower alkyl is a substituent. tuent preferred.
The formulas IIIa, IIlb and 1lIc include compounds such as N-chlorosuccinimide, N-bromosuccinimide, N-halo-lower alkanoylamide, e.g. N-chloroacetamide, N-chlorosulphonamide such as N-chlorobenzenesulphonamide, N-chloro-p-toluenesulphonamide and the like. like
Any catalyst which forms free radicals and which brings about the halogenation of compounds of the formula II can be used in the process according to the invention. Ge suitable catalysts are azo-bis-lower alkyl nitriles such as azobisisobutyronitrile, di-lower alkyl peroxides such as di-tert. -Butyl peroxides, diacyl peroxides such as di-lower alkanoyl peroxides (e.g. acetyl peroxide),
Peresters such as tert-butyl perbenzoate and tert-butyl perphthalate, hydroperoxides such as tert-butyl hydroperoxide, cumene hydroperoxide and the like. Azodiisobutyronitrile is preferred.
In a preferred embodiment, the 1-talogenation is carried out in an inert organic solvent. Suitable inert organic solvents are aromatic hydrocarbons such as benzene, xylene, toluene and the like; chlorinated hydrocarbons such as chlorobenzene, carbon tetrachloride and the like. Temperature and pressure are not of long in this process step and it can therefore be worked at room temperature and atmospheric pressure or above room temperature.
However, every person skilled in the art is familiar with the fact that the temperature at which the halogenation of compounds of the formula II is carried out is partly determined by the catalyst. It is known that some radical formations that are caused by cleavage of a bond take place at room temperature. The reaction can therefore be carried out at room temperature if a catalyst is used which dissociates at room temperature. Most catalysts which form free radicals only dissociate above room temperature. It is therefore preferred to carry out this step at suitable temperatures, preferably at the reflux temperature of the reaction medium.
The second step of the process according to the invention comprises the conversion of the 3-H <<log-1,4-benzodi2tze- pine into corresponding compounds of formula 1.
This can be done by treating a 3-halogen compound with ammonia in the presence of an inert organic solvent such as dichloromethane.
The 3-amino compounds of the formula I obtained can, if desired, be converted into 3-hydroxy compounds by diazotization and subsequent heating with water.
The expression all <yl up to 7 carbon atoms includes branched and unbranched hydrocarbon groups, such as meth, I, ethyl, n-propyl, isopropyl, isobutyl and the like. The expression (#Halogena includes all 4-halogens, i.e. iodine, Bromine, chlorine and fluorine, unless otherwise stated.
The term eniederes .Acyl.) Denotes acyl radicals of aromatic carboxylic acids, such as benzoyl or a branched or unbranched lower alkanoyl radical, e.g. Acetyl, propionyl and the like. Suitable alkali and alkaline earth metals are sodium. Potassium, calcium, magnesium and dal.
In compounds of the formula 1, A is preferably phenyl or 7-pyridyl, R is preferably hydrogen and R is preferably halogen, particularly preferably chlorine.
In the following example, all temperatures are given in C. <I> Example </I> A solution of 5.4 g (0.02 mol) 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, 3 g (0.022 mol) of N-chlorosuccinimide, 0.1 g of azodiisobutyronitrile and 200 ml of benzene are refluxed for 1 hour.
The suspension obtained is evaporated to dryness and the residue, which contains 3,7-dichloro-1,3-dihydro-5-phenyl-2H-1,4- benzodiazepin-2-one, is suspended in 50 ml dichloromethane . The suspension obtained is added, with stirring, to 100 ml of dichloromethane which is saturated with ammonia. The mixture is stirred in an ice bath for 1 hour and at room temperature for 3 hours. The dichloromethane is removed in vacuo. The oily residue is taken up in 35 ml of acetonitrile and heated to reflux.
After filtering, the acetonitrile filtrate is evaporated to dryness. Fractional recrystallization of the residue from ethanol gives red-brown 3-amino-7- - chloro-1,3 - dihydro-5-phenyl-2H-1,4 - benzodiazepin-2-one with a melting point of 187-192 (Zerr.) . After recrystallization from acetonitrile, pale brown crystals with a melting point of 218-22t) (decomp.) Are obtained.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US512795A US3371084A (en) | 1965-12-09 | 1965-12-09 | Process for preparing halogen-substituted-1, 4-benzodiazepines |
| CH1705466A CH482692A (en) | 1965-12-09 | 1966-11-28 | Process for the preparation of benzodiazepine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH488712A true CH488712A (en) | 1970-04-15 |
Family
ID=25718939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1642169A CH488712A (en) | 1965-12-09 | 1966-11-28 | Process for the preparation of benzodiazepine derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH488712A (en) |
-
1966
- 1966-11-28 CH CH1642169A patent/CH488712A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1545952C3 (en) | 7-ChIoM, 3-dlhydro-i - (2-hydroxyethyl) -5-phenyl-2H-1,4-benzodiazepin-2-one | |
| CH488712A (en) | Process for the preparation of benzodiazepine derivatives | |
| AT266146B (en) | Process for the preparation of benzodiazepine derivatives | |
| AT267531B (en) | Process for the preparation of benzodiazepine derivatives | |
| DE1695169A1 (en) | Process for the preparation of benzodiazepine derivatives | |
| DE69922363T2 (en) | PROCESS FOR PREPARING PESTICIDE INTERCONNECTIONS | |
| DE1290143B (en) | 2-Oxo-1, 2-dihydro-3H-1, 4-benzodiazepine derivatives | |
| DE1695174A1 (en) | Process for the preparation of benzodiazepine derivatives | |
| DE2256614C3 (en) | Process for the preparation of 2- (2-aminobenzoyO-pyridines | |
| AT344179B (en) | PROCESS FOR THE PREPARATION OF NEW BENZODIAZEPINE DERIVATIVES | |
| AT256113B (en) | Process for the preparation of benzodiazepine derivatives | |
| AT302325B (en) | Process for the preparation of new benzodiazepine derivatives and salts of these compounds | |
| AT274816B (en) | Process for the preparation of 1,2-dihydrobenzodiazepines and of acid addition salts of these compounds | |
| AT276401B (en) | Process for the preparation of benzodiazepine derivatives | |
| AT275531B (en) | Process for the preparation of benzodiazepine derivatives | |
| AT256853B (en) | Process for the preparation of new benzodiazepine derivatives | |
| DE1670802C (en) | Process for the production of Indoldenvaten | |
| DE1813241C3 (en) | ||
| DE2525851C2 (en) | ||
| AT308117B (en) | Process for the preparation of 1-alkyl-1,2,4,5-tetrahydro-3H-1,4-benzodiazepines and salts thereof | |
| AT266144B (en) | Process for the preparation of benzodiazepine derivatives | |
| DE1817791A1 (en) | Benzodiazepine derivs - tranquilisers, muscle relaxants, hypnotics | |
| AT270652B (en) | Process for the preparation of benzodiazepine derivatives | |
| AT251588B (en) | Process for the production of quinazoline derivatives | |
| AT256112B (en) | Process for the preparation of benzodiazepine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLZ | Patent of addition ceased |